Moreover, ROC curve-based analysis also demonstrated the excellent performance of CDKN2B-AS1 in forecasting the occurrence of LC, which preliminarily suggested the potential of CDKN2B-AS1 to one marker of LC. This evidence concerns the gene CDKN2B and laryngotracheoesophageal cleft.